Kim BH - Search Results

1

Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA.

Bae M, Kim G, Lee TR, Ahn JM, Park H, Park SR, Song KB, Jun E, Oh D, Lee JW, Park YS, Song KW, Byeon JS, Kim BH, Sohn JH, Kim MH, Kim GM, Chie EK, Kang HC, Kong SY, Woo SM, Lee JE, Ryu JM, Lee J, Kim D, Ki CS, Cho EH, Choi JK. Bae M, et al. Among authors: kim g, kim d, kim bh, kim gm, kim mh. Nat Commun. 2023 Apr 10;14(1):2017. doi: 10.1038/s41467-023-37768-3. Nat Commun. 2023. PMID: 37037826 Free PMC article.

2

The Prognostic Significance of Protein Expression of CASZ1 in Clear Cell Renal Cell Carcinoma.

Kim B, Jung M, Moon KC. Kim B, et al. Dis Markers. 2019 Aug 6;2019:1342161. doi: 10.1155/2019/1342161. eCollection 2019. Dis Markers. 2019. PMID: 31481981 Free PMC article.

3

Quantitative proteomics identifies TUBB6 as a biomarker of muscle-invasion and poor prognosis in bladder cancer.

Kim B, Jung M, Moon KC, Han D, Kim K, Kim H, Yang S, Lee D, Jun H, Lee KM, Lee CH, Nikas IP, Yang S, Lee H, Ryu HS. Kim B, et al. Int J Cancer. 2023 Jan 15;152(2):320-330. doi: 10.1002/ijc.34265. Epub 2022 Sep 10. Int J Cancer. 2023. PMID: 36054443 Free article.

4

Immunohistochemistry of cytokeratin (CK) 5/6, CD44 and CK20 as prognostic biomarkers of non-muscle-invasive papillary upper tract urothelial carcinoma.

Jung M, Kim B, Moon KC. Jung M, et al. Histopathology. 2019 Feb;74(3):483-493. doi: 10.1111/his.13763. Epub 2018 Dec 2. Histopathology. 2019. PMID: 30286252

5

Primary renal well-differentiated neuroendocrine tumors: report of six cases with an emphasis on the Ki-67 index and mitosis.

Kim B, Kim HS, Moon KC. Kim B, et al. Diagn Pathol. 2019 Feb 7;14(1):12. doi: 10.1186/s13000-019-0791-7. Diagn Pathol. 2019. PMID: 30732641 Free PMC article.

6

A case of invasive squamous cell carcinoma on the surface of pedunculated cervical leiomyoma presenting an exophytic cervical cancer.

Rim Nam H, Jae Huh S, Taik Park C, Kim B, Ahn G. Rim Nam H, et al. Gynecol Oncol. 2005 Apr;97(1):253-5. doi: 10.1016/j.ygyno.2004.12.021. Gynecol Oncol. 2005. PMID: 15790470

7

Clinicopathologic Features of Benign Neurogenic Tumor of Urinary Bladder.

Lee C, Kim B, Song B, Park JH, Moon KC. Lee C, et al. Int J Surg Pathol. 2018 May;26(3):221-228. doi: 10.1177/1066896917742722. Epub 2017 Nov 26. Int J Surg Pathol. 2018. PMID: 29172920

8

Comprehensive Gene Expression Analyses of Immunohistochemically Defined Subgroups of Muscle-Invasive Urinary Bladder Urothelial Carcinoma.

Kim B, Jang I, Kim K, Jung M, Lee C, Park JH, Kim YA, Moon KC. Kim B, et al. Int J Mol Sci. 2021 Jan 10;22(2):628. doi: 10.3390/ijms22020628. Int J Mol Sci. 2021. PMID: 33435173 Free PMC article.

9

Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment-naïve patients: A single-center study.

Nikas IP, Lee C, Song MJ, Kim B, Ryu HS. Nikas IP, et al. Cancer Med. 2022 Jun;11(11):2193-2203. doi: 10.1002/cam4.4600. Epub 2022 Feb 25. Cancer Med. 2022. PMID: 35212471 Free PMC article.

10

Nicotinamide (niacin) supplement increases lipid metabolism and ROS-induced energy disruption in triple-negative breast cancer: potential for drug repositioning as an anti-tumor agent.

Jung M, Lee KM, Im Y, Seok SH, Chung H, Kim DY, Han D, Lee CH, Hwang EH, Park SY, Koh J, Kim B, Nikas IP, Lee H, Hwang D, Ryu HS. Jung M, et al. Mol Oncol. 2022 May;16(9):1795-1815. doi: 10.1002/1878-0261.13209. Epub 2022 Mar 25. Mol Oncol. 2022. PMID: 35278276 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,174 results

Search Page